Assay and Drug Development Technologies

Papers
(The H4-Index of Assay and Drug Development Technologies is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
On the Recent Changes to Animal Protection Measures in United States Food and Drug Administration Policy38
Novel Therapeutics Involving Antibiotic Polymer Conjugates for Treating Various Ailments: A Review23
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line22
A Perspective on Various Facets of Nanoemulsions and its Commercial Utilities22
Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems15
Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective14
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability Modifier13
Investigating the Role of Buzhong Yiqi Decoction on Neurogenic Bladder with Network Pharmacology, Molecular Docking, and In Vitro Assays13
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells12
Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument11
Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes11
0.058240175247192